LONDON, UK—-29th April 2010—-New Publications. Today UK-based strategic research consultancy VacZine Analytics releases a new commercial market forecast for Pseudomonas aeruginosa vaccines MarketVIEW: Pseudomonas aeruginosa vaccines models the global market for a vaccine to prevent life-threatening infections from this problematic hospital pathogen. The product gives a comprehensive vaccine value ($USD/volume (000s) forecast for all potential risk population indications that would benefit from a preventative strategy. The model includes LO/BASE/HI forecast scenarios so the user can visualize the commercial impact of differing targetting/competitive and pricing scenarios to 2030. VISIT SITE TO LEARN MORE.
